We are live on
!
Find out more
AAM
Auxier Asset Management Portfolio holdings
AUM
$696M
1-Year Est. Return
18.07%
This Fund
S&P 500
This Quarter
Est. Return
+8.29%
1 Year Est. Return
+18.07%
3 Year Est. Return
+58.42%
5 Year Est. Return
+82.9%
10 Year Est. Return
+252.62%
AUM
$441M
AUM Growth
+$13M
(+3%)
Cap. Flow
-$15.7M
Cap. Flow
% of AUM
-3.57%
Top 10 Holdings %
Top 10 Hldgs %
29.7%
Holding
148
New
10
Increased
10
Reduced
66
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$2.07M |
| 2 |
STJ
St Jude Medical
STJ
|
+$1.39M |
| 3 |
Merck
MRK
|
+$630K |
| 4 |
Warner Bros
WBD
|
+$451K |
| 5 |
Capri Holdings
CPRI
|
+$416K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altera Corp
ALTR
|
+$4.16M |
| 2 |
Tapestry
TPR
|
+$1.09M |
| 3 |
UN
Unilever NV New York Registry Shares
UN
|
+$872K |
| 4 |
UnitedHealth
UNH
|
+$871K |
| 5 |
Procter & Gamble
PG
|
+$768K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 25.05% |
| 2 | Healthcare | 23.41% |
| 3 | Financials | 18.22% |
| 4 | Communication Services | 6.91% |
| 5 | Technology | 6.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Principal Financial Group
PFG
$24.3B
| $239K | 0.05% |
5,322
| – | – |
|
127
Gilead Sciences
GILD
$162B
| $231K | 0.05% |
+2,282
| New | +$237K |
|
|
DISCK
128
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $217K | 0.05% |
8,598
| – | – |
|
129
SK Telecom
SKM
$12.1B
| $210K | 0.05% |
6,318
-60
| -0.9% | -$2.26K |
|
130
Arcos Dorados Holdings
ARCO
$1.72B
| $208K | 0.05% |
68,657
+48,103
| +234% | +$145K |
|
131
Fastenal
FAST
$54.7B
| $208K | 0.05% |
+20,400
| New | +$201K |
|
|
DAI
132
DELISTED
DAIMLER AG
DAI
| $206K | 0.05% |
+2,459
| New | +$206K |
|
|
CDK
133
DELISTED
CDK Global, Inc.
CDK
| $204K | 0.05% |
4,288
| – | – |
|
|
JWN
134
DELISTED
Nordstrom
JWN
| $203K | 0.05% |
4,078
| – | – |
|
135
HP
HPQ
$24.9B
| $188K | 0.04% |
15,904
-19,634
| -55% | -$251K |
|
|
ZYNE
136
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $180K | 0.04% |
+17,857
| New | +$236K |
|
137
Ideal Power
IPWR
$60.8M
| $115K | 0.03% |
+1,438
| New | +$113K |
|
138
Nokia
NOK
$51B
| $92K | 0.02% |
13,110
-200
| -2% | -$1.43K |
|
|
WG
139
DELISTED
Willbros Group
WG
| $33K | 0.01% |
12,175
-600
| -5% | -$1.45K |
|
140
Perspective Therapeutics
CATX
$332M
| $13K | ﹤0.01% |
1,422
| – | – |
|
141
Andersons Inc
ANDE
$2.41B
| – | – |
-5,890
| Closed | -$201K |
|
142
Alphabet (Google) Class C
GOOG
$4.36T
| – | – |
-10,300
| Closed | -$329K |
|
|
ALTR
143
DELISTED
Altera Corp
ALTR
| – | – |
-83,103
| Closed | -$4.16M |
|
Similar funds
JA
CA
GUB
BBPWM
SCM
KLI
WIC
MCM
Auxier Asset Management's Q4 2015 Portfolio in Review
As of Q4 2015, Auxier Asset Management held 148 positions worth $441M, up 3% from $428M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Auxier Asset Management withdrew a net $15.7M in Q4 2015, closing 3 positions and reducing 66 holdings. Its most notable exit was Altera Corp, an estimated $4.16M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Auxier Asset Management opened a new position in Biogen worth $2.2M.
- Auxier Asset Management's largest Q4 2015 buy was Biogen: 7,195 shares worth $2.2M.
- Auxier Asset Management added most to Merck in Q4 2015, an estimated $630K increase.
- Auxier Asset Management's biggest Q4 2015 reduction was Tapestry, cutting an estimated $1.09M.
- Auxier Asset Management fully exited Altera Corp in Q4 2015, selling an estimated $4.16M.
- Auxier Asset Management's ten largest holdings make up 30% of its $441M portfolio in Q4 2015.
- Auxier Asset Management opened 10 new positions and closed 3 in Q4 2015.
- Auxier Asset Management's portfolio value rose 3% quarter-over-quarter to $441M.
Based on Auxier Asset Management's 13F filing for Q4 2015, filed 8 Feb 2016.